Gender differences in GAD antibody - Positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases

Diabetes/Metabolism Research and Reviews

Volumn 20, Issue 2, 2004, Pages 158-164

  Lindholm, Eero ^a   Hallengrem, Bengt ^a   Agardh, Carl David ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoimmunity; C peptide concentrations; Diabetes mellitus; GAD antibodies; Gender

Indexed keywords

C PEPTIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; GONADORELIN; SEX HORMONE;

ADULT; ANAMNESIS; ARTICLE; AUTOIMMUNE DISEASE; BODY MASS; CELL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE DURATION; ENDOCRINE DISEASE; FEMALE; FREQUENCY ANALYSIS; GROUPS BY AGE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; ONSET AGE; PANCREAS ISLET BETA CELL; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCREENING TEST; SEX DIFFERENCE; STATISTICAL ANALYSIS; THYROID DISEASE; THYROID FUNCTION TEST;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; C-PEPTIDE; COMORBIDITY; DIABETES MELLITUS, TYPE 1; ENDOCRINE SYSTEM DISEASES; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; THYROID DISEASES;

EID: 1842843077     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.420     Document Type: Article

References (32)

1. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986; 314: 1360-1368.
2. Baekkeskov S, Aanstoot HJ, Christgau S, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-156.
3. Lan MS, Lu J, Goto Y, Notkins AL. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994; 13: 505-514.
4. Shimada A, Imazu Y, Morinaga S, et al. T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report. Diabetes Care 1999; 22: 615-617.
5. Imagawa A, Hanafusa T, Itoh N, et al. Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset type I (insulin-dependent) diabetes mellitus. Diabetologia 1999; 42: 574-578.
6. Suzuki R, Shimada A, Maruyama T, et al. T-cell function in anti-GAD65(+)diabetes with residual beta-cell function. J Autoimmun 2003; 20: 83-90.
7. Borg H, Gottsater A, Landin-Olsson M, Fernlund P, Sundkvist G. High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age. J Clin Endocrinol Metab 2001; 86: 3032-3038.
8. Lohmann T, Kellner K, Verlohren HJ, et al. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 2001; 44: 1005-1010.
9. Zimmet PZ, Elliott RB, Mackay IR, et al. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender. Diabet Med 1994; 11: 866-871.
10. Williams AJ, Bingley PJ, Moore WP, Gale EA. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with type I diabetes. Diabetologia 2002; 45: 217-223.
11. Papadopoulos KI, Hallengren B. Polyglandular autoimmune syndrome type II in patients with idiopathic Addison's disease. Acta Endocrinol (Copenh) 1990; 122: 472-478.
12. Riley WJ. Autoimmune polyglandular syndromes. Horm Res 1992; 38(Suppl. 2): 9-15.
13. Jaeger C, Hatziagelaki E, Petzoldt R, Bretzel RG. Comparative analysis of organ-specific autoantibodies and celiac disease-associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects. Diabetes Care 2001; 24: 27-32.
14. Tuomi T, Carlsson A, Li H, et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999; 48: 150-157.
15. Bagchi N, Brown TR, Parish RF, Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med 1990; 150: 785-787.
16. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-493.
17. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham study. Arch Intern Med 1985; 145: 1386-1388.
18. Riley WJ, Maclaren NK, Lezotte DC, Spillar RP, Rosenbloom AL. Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr 1981; 99: 350-354.
19. Chiovato L, Lapi P, Fiore E, Tonacchera M, Pinchera A. Thyroid autoimmunity and female gender. J Endocrinol Invest 1993; 16: 384-391.
20. Tanriverdi F, Silveira LF, MacColl GS, Bouloux PM. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol 2003; 176: 293-304.
21. WHO Study Group. World Health Organization Technical Report Series 727, World Health Organization: Geneva, 1985.
22. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
23. Mire-Sluis AR, Das RG, Lernmark A. The development of a World Health Organisation international standard for islet cell antibodies: the aims and design of an international collaborative study. Diabetes Metab Res Rev 1999; 15: 72-77.
24. Verge CF, Stenger D, Bonifacio E, et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: combinatorial islet autoantibody workshop. Diabetes 1998; 47: 1857-1866.
25. Li H, Lindholm E, Almgren P, et al. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 574-582.
26. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a noninsulin-dependent onset of disease. Diabetes 1993; 42: 359-362.
27. Turner R, Stratton I, Horton V, et al., UK Prospective Diabetes Study Group. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 1997; 350: 1288-1293.
28. Gottsater A, Landin-Olsson M, Lernmark A, Fernlund P, Sundkvist G, Hagopian WA. Glutamate decarboxylase antibody levels predict rate of beta-cell decline in adult-onset diabetes. Diabetes Res Clin Pract 1995; 27: 133-140.
29. Zimmet P, Turner R, McCarty D, Rowley M, Mackay I. Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diabetes Care 1999; 22(Suppl. 2): B59-B64.
30. Lindholm E, Agardh E, Tuomi T, Groop L, Agardh CD. Classifying diabetes according to the new WHO clinical stages. Eur J Epidemiol 2001; 17: 983-989.
31. Einarsdottir E, Soderstrom I, Lofgren-Burstrom A, et al. The CTLA4 region as a general autoimmunity factor: An extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves'disease. Eur J Hum Genet 2003; 11: 81-84.
32. Awata T, Kurihara S, Iitaka M, et al. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 1998; 47: 128-129.